IN8BIO, Inc. INAB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:46 PM EDT
2.29quote price arrow up+0.09 (+4.09%)
Volume
457
Close
2.20quote price arrow up+0.05 (+2.33%)
Volume
23,588
52 week range
1.90 - 10.32
Loading...
  • Open2.16
  • Day High2.29
  • Day Low2.11
  • Prev Close2.15
  • 52 Week High10.32
  • 52 Week High Date08/11/21
  • 52 Week Low1.90
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap41.45M
  • Shares Out18.84M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-49.89

KEY STATS

  • Open2.16
  • Day High2.29
  • Day Low2.11
  • Prev Close2.15
  • 52 Week High10.32
  • 52 Week High Date08/11/21
  • 52 Week Low1.90
  • 52 Week Low Date06/16/22
  • Market Cap41.45M
  • Shares Out18.84M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-49.89

RATIOS/PROFITABILITY

  • EPS (TTM)-1.02
  • P/E (TTM)-2.16
  • Fwd P/E (NTM)-2.75
  • EBITDA (TTM)-17.744M
  • ROE (TTM)-248.76%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)1.60%

EVENTS

  • Earnings Date09/10/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On IN8BIO, Inc.

There is no recent news for this security.

Profile

MORE
IN8bio, Inc. is a cell analysis solutions company. The Company is focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. The Company develops ex vivo-expanded and activated gamma-delta T cell candidates based upon its capabilities in gamma-delta T cell biology, genetic engineering and cell-type-specific manufacturing capabilities, DeltEx platform. Its lead product candidate, INB-200, is a genetically modified...
Alan Roemer
Independent Chairman of the Board
William Ho
President, Chief Executive Officer, Director
Kate Rochlin Ph.D.
Chief Operating Officer
Patrick Mccall CPA
Chief Financial Officer
Stacey Bilinski
Vice President - Clinical Operations
Address
Empire State Building
350 5Th Avenue, Suite 5330
New York, NY
10118
United States